WO2002047607A3 - Process for the preparation of a fast dissolving dosage form - Google Patents

Process for the preparation of a fast dissolving dosage form Download PDF

Info

Publication number
WO2002047607A3
WO2002047607A3 PCT/IB2001/002354 IB0102354W WO0247607A3 WO 2002047607 A3 WO2002047607 A3 WO 2002047607A3 IB 0102354 W IB0102354 W IB 0102354W WO 0247607 A3 WO0247607 A3 WO 0247607A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
dosage form
fast dissolving
dissolving dosage
tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2001/002354
Other languages
French (fr)
Other versions
WO2002047607A2 (en
Inventor
Deepak Murpani
Rajiv Malik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Priority to AU2002220968A priority Critical patent/AU2002220968A1/en
Priority to EP01270300A priority patent/EP1343481A4/en
Publication of WO2002047607A2 publication Critical patent/WO2002047607A2/en
Publication of WO2002047607A3 publication Critical patent/WO2002047607A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a process for the preparation of fast dissolving dosage form, such as tablet, which disintegrates quickly in the mouth. The process of this invention is particularly suitable for moisture sensitive, poorly compressible and bitter drugs having a taste mask coating.
PCT/IB2001/002354 2000-12-15 2001-12-07 Process for the preparation of a fast dissolving dosage form Ceased WO2002047607A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2002220968A AU2002220968A1 (en) 2000-12-15 2001-12-07 Process for the preparation of a fast dissolving dosage form
EP01270300A EP1343481A4 (en) 2000-12-15 2001-12-07 Process for the preparation of a fast dissolving dosage form

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1170DE2000 IN192750B (en) 2000-12-15 2000-12-15
IN1170/DEL/2000 2000-12-15

Publications (2)

Publication Number Publication Date
WO2002047607A2 WO2002047607A2 (en) 2002-06-20
WO2002047607A3 true WO2002047607A3 (en) 2003-03-20

Family

ID=11097139

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2001/002354 Ceased WO2002047607A2 (en) 2000-12-15 2001-12-07 Process for the preparation of a fast dissolving dosage form

Country Status (4)

Country Link
EP (1) EP1343481A4 (en)
AU (1) AU2002220968A1 (en)
IN (1) IN192750B (en)
WO (1) WO2002047607A2 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8858210B2 (en) 2009-09-24 2014-10-14 Mcneil-Ppc, Inc. Manufacture of variable density dosage forms utilizing radiofrequency energy
US8865204B2 (en) 2009-09-24 2014-10-21 Mcneil-Ppc, Inc. Manufacture of lozenge product with radiofrequency
US8968769B2 (en) 2007-10-31 2015-03-03 Mcneil-Ppc, Inc. Orally disintegrative dosage form
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10232113A1 (en) 2002-07-16 2004-01-29 Bayer Ag Medicinal products containing vardenafil hydrochloride trihydrate
KR100503949B1 (en) * 2003-04-28 2005-07-26 주식회사유한양행 A composition of fast dissolving tablets effectively masked bitter taste of ondansetron hydrochloride
FR2858556B1 (en) * 2003-08-06 2006-03-10 Galenix Innovations DISPERSIBLE AND / OR ORODISPERSIBLE SOLID PHARMACEUTICAL COMPOSITION, NOT PELLETIZED, CONTAINING AT LEAST THE METFORMIN ACTIVE INGREDIENT, AND PROCESS FOR PREPARING THE SAME
EP1510208A1 (en) 2003-08-22 2005-03-02 Fournier Laboratories Ireland Limited Pharmaceutical composition comprising a combination of metformin and statin
WO2005062722A2 (en) * 2003-11-21 2005-07-14 Sun Pharmaceutical Industries Limited Fexofenadine containing pharmaceutical formulation
US20090060983A1 (en) * 2007-08-30 2009-03-05 Bunick Frank J Method And Composition For Making An Orally Disintegrating Dosage Form
EP2044929A1 (en) * 2007-10-04 2009-04-08 Laboratorios del Dr. Esteve S.A. Oral fast distintegrating tablets
DE102008047910A1 (en) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tabletting excipient based on lactose and cellulose
US8581001B2 (en) 2010-04-16 2013-11-12 Codman & Shurtleff Metformin-cysteine prodrug
US9119793B1 (en) 2011-06-28 2015-09-01 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for doxycycline
CN102258497B (en) * 2011-08-18 2013-01-09 海南良方医药有限公司 Lamivudine tablet composition and preparation method thereof
US10842802B2 (en) 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms
CN103432091A (en) * 2013-09-13 2013-12-11 钟术光 Improved-performance tablet and preparation method thereof
BR112016015944A8 (en) 2014-01-10 2020-06-09 Johnson & Johnson Consumer Inc process to produce tablet, which uses radiofrequency and coated particles dissipating energy
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
ES2961850T3 (en) 2019-02-22 2024-03-14 Catalent Uk Swindon Zydis Ltd Minimization of suspension aeration during in-line mixing
KR20210129649A (en) 2019-02-22 2021-10-28 카탈렌트 유.케이. 스윈던 지디스 리미티드 Minimize aggregation, aeration and preserve coating of pharmaceutical compositions containing ibuprofen
JP7543291B2 (en) 2019-02-22 2024-09-02 キャタレント・ユーケー・スウィンドン・ザイディス・リミテッド Minimize agglomeration of drug particle coating materials during storage to stabilize drug disintegration times
AU2020225818B2 (en) 2019-02-22 2025-09-18 Catalent U.K. Swindon Zydis Limited Preserving functionally-coated API particles produced by solventless mixing processes in aqueous suspension
US11179331B1 (en) 2020-04-21 2021-11-23 Cure Pharmaceutcai Holding Corp Oral soluble film containing sildenafil citrate
PT3962455T (en) 2020-05-18 2022-10-13 Orexo Ab New pharmaceutical composition for drug delivery
US12208160B2 (en) 2020-07-31 2025-01-28 Catalent U.K. Swindon Zydis Limited Pharmaceutical compositions comprising coated API
GB202117016D0 (en) 2021-11-25 2022-01-12 Orexo Ab New pharmaceutical device
AR127780A1 (en) 2021-11-25 2024-02-28 Orexo Ab NEW PHARMACEUTICAL COMPOSITION THAT COMPRISES ADRENALINE

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946684A (en) * 1989-06-20 1990-08-07 American Home Products Corporation Fast dissolving dosage forms
US5631023A (en) * 1993-07-09 1997-05-20 R.P. Scherer Corporation Method for making freeze dried drug dosage forms
US5866163A (en) * 1993-09-10 1999-02-02 Fuisz Technologies Ltd. Process and apparatus for making rapidly dissolving dosage units and product therefrom
US6083531A (en) * 1996-04-16 2000-07-04 Novartis Consumer Health S.A. Fast disintegrating oral dosage form

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6115830A (en) * 1984-06-28 1986-01-23 ザ　プロクタ−　アンド　ガンブル　カンパニ− Antacid composition and manufacture
GB2293099A (en) * 1994-09-15 1996-03-20 Mailway Packaging Group Ltd Drug formulation
WO1999043306A1 (en) * 1998-02-26 1999-09-02 Banyu Pharmaceutical Co., Ltd. An orally disintegrating composition and its manufacturing method
GT199900061A (en) * 1998-05-15 2000-10-14 Pfizer PHARMACEUTICAL FORMULATIONS.

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946684A (en) * 1989-06-20 1990-08-07 American Home Products Corporation Fast dissolving dosage forms
US5631023A (en) * 1993-07-09 1997-05-20 R.P. Scherer Corporation Method for making freeze dried drug dosage forms
US5866163A (en) * 1993-09-10 1999-02-02 Fuisz Technologies Ltd. Process and apparatus for making rapidly dissolving dosage units and product therefrom
US6083531A (en) * 1996-04-16 2000-07-04 Novartis Consumer Health S.A. Fast disintegrating oral dosage form

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1343481A4 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8968769B2 (en) 2007-10-31 2015-03-03 Mcneil-Ppc, Inc. Orally disintegrative dosage form
US8858210B2 (en) 2009-09-24 2014-10-14 Mcneil-Ppc, Inc. Manufacture of variable density dosage forms utilizing radiofrequency energy
US8865204B2 (en) 2009-09-24 2014-10-21 Mcneil-Ppc, Inc. Manufacture of lozenge product with radiofrequency
US8871263B2 (en) 2009-09-24 2014-10-28 Mcneil-Ppc, Inc. Manufacture of tablet in a die utilizing radiofrequency energy and meltable binder
US9107807B2 (en) 2009-09-24 2015-08-18 Mcneil-Ppc, Inc. Machine for the manufacture of dosage forms utilizing radiofrequency energy
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet

Also Published As

Publication number Publication date
IN192750B (en) 2004-05-15
AU2002220968A1 (en) 2002-06-24
EP1343481A2 (en) 2003-09-17
EP1343481A4 (en) 2004-03-17
WO2002047607A2 (en) 2002-06-20

Similar Documents

Publication Publication Date Title
WO2002047607A3 (en) Process for the preparation of a fast dissolving dosage form
WO2004069198A3 (en) Sugar-free oral transmucosal solid dosage forms and uses thereof
MXPA02003596A (en) Novel pharmaceutical compositions of anti-tubercular drugs and process for their preparation.
AU2002216701A1 (en) Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
PT1094788E (en) DISSIMULATION OF FLAVOR WITH CROSCARMELOSE
WO2002094774A3 (en) Oxcarbazepine dosage forms
UA63993C2 (en) Pharmaceutical flash-melt oral dosage forms (variants) and method for their preparation
WO2001068092A3 (en) Glycogen phosphorylase inhibitor
MXPA03006476A (en) Pharmaceutical dosage forms of epothilones for oral administration.
WO2002045684A3 (en) Rapidly dispersing pharmaceutical composition comprising effervescent agents
AU2002357012A1 (en) Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
HUP0203540A2 (en) Extended release formulations of erythromycin derivatives
GR1004522B (en) Cefuroxime axetil-based pharmaceutical composition
PL367447A1 (en) Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient
WO2003026610A3 (en) Process for the preparation of fast dissolving dosage form
IL150528A0 (en) Ibuprofen containing active agent preparation
EP1238662A3 (en) Method for manufacturing drug granules, the drug granules and pharmaceutical preparation containing the drug granules
WO2003034991A3 (en) Taste masking spill-resistant formulation
TNSN04173A1 (en) Tasteless directly compressible fast-dissolving complexes and pharmaceutical formulations thereof
ZA200208761B (en) Pharmaceutical form of administration for peptides, methods for its production and use.
HUP0202233A3 (en) Derivatives and analogues of galanthamin, their use, pharmaceutical compositions containing them and process for the preparation of them
MXPA04002714A (en) Use of 2-oxo-1-pyrrolidine derivatives for the preparation of a drug.
SG116507A1 (en) Pharmaceutical dosage form and method of making.
WO2007031887A3 (en) Extended release pharmaceutical composition of metformin and a process for producing it
MXPA03001752A (en) Pharmaceutical formulation of salmeterol and fluticasone propionate.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001270300

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001270300

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001270300

Country of ref document: EP